| ENOB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ENOB shares outstanding history going back to 11/13/2018:
Also see: ENOB Market Cap History ENOB YTD Return |
ENOB Shares Outstanding History — Enochian Biosciences Share Count Over Time
As of 9/29/2023 Enochian Biosciences has 65.70 million ENOB shares outstanding. Investors often track the ENOB shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ENOB share count trends over time, with 22 historical shares outstanding datapoints presented, dating back to 11/13/2018.
| ENOB Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
ENOB Historical Shares Outstanding: +13.02% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| ENOB Stock Price Chart |
| About Enochian Biosciences Inc |
| Enochian BioSciences is a pre-clinical stage biotechnology company. Co.'s product candidates include: ENOB-HV-01 for autologous Human Immunodeficiency Virus (HIV) curative treatment; ENOB-HV-11 for preventive HIV vaccine; ENOB-HV-12 for therapeutic HIV vaccine; ENOB-HV-21 for HIV natural killer and gamma delta T-cell treatment or cure; ENOB-HV-31 for in vivo gene therapy; ENOB-HB-01 for hijacking Hepatitis B Virus polymerase; ENOB-CV-01 for coronavirus treatment; ENOB-CV-11 for coronavirus prophylaxis; ENOB-FL-01 for influenza treatment; ENOB-FL-11 for influenza prophylaxis; and ENOB-DC-11 for off the shelf dendritic cell vaccine for multiple solid tumors. We show 22 historical shares outstanding datapoints in our coverage of ENOB's shares outstanding history. Understanding the changing numbers of ENOB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ENOB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ENOB by allowing them to research ENOB shares outstanding history as well as any other stock in our coverage universe. |
| ENOB Current Stock Quote |
Quotes delayed 20 minutes  Free ENOB Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ENOB Share Performance |
| Shares Outstanding Peers |
| Enochian Biosciences (ENOB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ENOV Shares Outstanding History ENSC Shares Outstanding History ENSG Shares Outstanding History ENTA Shares Outstanding History ENTO Shares Outstanding History ENVB Shares Outstanding History ENZ Shares Outstanding History EOLS Shares Outstanding History EPZM Shares Outstanding History EQ Shares Outstanding History More Healthcare companies » |
ENOB Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
